RenovoRx

Performance

About RenovoRx

RenovoRx is a life sciences company focused on developing targeted oncology therapies and commercializing the RenovoCath catheter for localized drug delivery. The company advances the Trans-Arterial Micro-Perfusion (TAMP) therapy platform to deliver chemotherapy intra-arterially near pancreatic tumor sites, aiming to improve safety and efficacy for solid tumor cancers. Located in Mountain View, California, RenovoRx also conducts Phase III clinical research (TIGeR-PaC) evaluating intra-arterial gemcitabine against systemic chemotherapy. The organization emphasizes novel, drug-device combination approaches to treat locally advanced pancreatic cancer and other solid tumors.